Plasmid-mediated resistance to cephalosporins in Salmonella enterica serovar typhi

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3991-3992

  Morita, Masatomo ^a   Takai, Nobuko ^a   Terajima, Jun ^a   Watanabe, Haruo ^a   Kurokawa, Manabu ^b   Sagara, Hiroko ^c   Ohnishi, Kenji ^d   Izumiya, Hidemasa ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KOBE INSTITUTE OF HEALTH   (Japan)

^c YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^d TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE CTX M15; CEPHALOSPORIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; GENE TRANSFER; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; SALMONELLA TYPHI; SEROTYPE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SALMONELLA TYPHI;

EID: 77956130627     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00225-10     Document Type: Article

References (12)

1. Al Naiemi, N., B. Zwart, C. Rijnsburger, R. Roosendaal, Y. J. Debet-Ossenkopp, J. A. Mulder, C. A. Fijen, W. Maten, C. M. Vandenbroucke- Grauls, and P. H. Savelkoul. 2008. Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. J. Clin. Microbiol. 46:2794-2795.
2. Bernstein, A., and E. M. J. Wilson. 1963. An analysis of the Vi-phage typing scheme for Salmonella typhi. J. Gen. Microbiol. 32:349-373.
3. Bhan, M. K., R. Bahl, and S. Bhatnagar. 2005. Typhoid and paratyphoid fever. Lancet 366:749-762.
4. Cantón, R., and T. M. Coque. 2006. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
5. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Connor, B. A., and E. Schwartz. 2005. Typhoid and paratyphoid fever in travellers. Lancet Infect. Dis. 5:623-628.
7. Gaind, R., B. Paglietti, M. Murgia, R. Dawar, S. Uzzau, P. Cappuccinelli, M. Deb, P. Aggarwal, and S. Rubino. 2006. Molecular characterization of ciprofloxacin- resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J. Antimicrob. Chemother. 58:1139-1144.
8. Morita, M., K. Hirose, N. Takai, J. Terajima, H. Watanabe, H. Sagara, T. Kurazono, M. Yamaguchi, Y. Kanazawa, T. Oyaizu, and H. Izumiya. 2010. Salmonella enterica serovar Typhi in Japan, 2001-2006; emergence of highlevel fluoroquinolone-resistant strains. Epidemiol. Infect. 138:318-321.
9. Pfeifer, Y., J. Matten, and W. Rabsch. 2009. Salmonella enterica serovar Typhi with CTX-M β-lactamase, Germany. Emerg. Infect. Dis. 15:1533-1535.
10. Pitout, J. D., and K. B. Laupland. 2008. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
11. Rotimi, V. O., W. Jamal, T. Pal, A. Sovenned, and M. J. Albert. 2008. Emergence of CTX-M-15 type extended-spectrum β-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J. Med. Microbiol. 57:881-886.
12. Threlfall, E. J., E. de Pinna, M. Day, J. Lawrence, and J. Jones. 2008. Alternatives to ciprofloxacin use for enteric fever, United Kingdom. Emerg. Infect. Dis. 14:860-861.